NsGene has created substantial values in its pipeline (overview below), both using its EC Biodelivery™ platform, and through its new biological entities. NsGene is seeking partners for its EC Biodelivery™ products for Alzheimer's disease (NsG0202), and Parkinson's disease, and partnerships for development of partner-specific molecules using the EC Biodelivery™ technology for other nervous system indications.
